A new medicine for attention-deficit/hyperactivity disorder (ADHD) has just entered the treatment toolbox: centanafadine, a once-daily tablet sold under the brand name Simtriyo.
16 hours ago
0
3
Researchers at Moffitt Cancer Center have developed three mathematical biomarkers that may help physicians personalize adaptive therapy for prostate cancer by predicting treatment outcomes early in treatment. The biomarkers ...
17 hours ago
0
6
Overreactions to ordinary sensory stimuli—a scratchy shirt tag, a roaring vacuum cleaner, an unfamiliar smell—are commonly associated with autism. But in fact, an estimated 15% to 20% of children experience such reactions, ...
17 hours ago
0
3
Integrating Māori and Pacific attitudes toward mental illness into health campaigns may result in a less judgmental Aotearoa New Zealand, a University of Otago–Ōtākou Whakaihu Waka-led study has found.
17 hours ago
0
2
Osteoarthritis is a leading cause of chronic pain and disability worldwide. Current intra-articular standards of care, such as analgesics, corticosteroids and viscosupplements, provide only transient symptomatic relief and ...
17 hours ago
0
11
Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have developed an automated system that uses MRI to measure brain tissue changes in animal ...
18 hours ago
0
7
Calls to poison centers involving liver injuries caused by medications, supplements, alcohol and other substances jumped nearly 400% between 2000 and 2024, according to a new study from UVA Health published in Clinical Gastroenterology ...
19 hours ago
0
267
The language network in your brain can be seen, even if you aren't saying a word. For a study published in Nature Communications, researchers used data from more than 1,900 functional magnetic resonance imaging (fMRI) scans ...
20 hours ago
1
38
